Clinical Trial Update: HIgh Dose Thymoglobulin Instead of Cyclosporine With a Low Dose of Thymoglobulin for GVHD Prophylaxis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating high-dose thymoglobulin with low-dose thymoglobulin as GVHD prophylaxis, substituting cyclosporine; the study NCT03456817 sponsored b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Thymoglobulin (rabbit anti-thymocyte globulin)

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Graft-versus-host-disease, Relapse | Phase 2 | Status: TERMINATED